The US allergy immunotherapy market is experiencing robust growth due to the rising prevalence of allergic rhinitis, asthma, and food allergies, coupled with increasing adoption of long-term treatment approaches. Advanced healthcare infrastructure, strong clinical research activities, and the presence of leading pharmaceutical companies are supporting the development and commercialization of...